Rheopheresis: Rheologic, Functional, and Structural Aspects
Authors:
- 1 October 2000
- journal article
- research article
- Published by Wiley in Therapeutic Apheresis
- Vol. 4 (5) , 348-357
Abstract
Rheopheresis is a specific application of membrane differential filtration, synonymous with double filtration plasmapheresis for extracorporeal hemorheotherapy, eliminating an exactly defined spectrum of high molecular weight proteins from human plasma (e.g.: fibrinogen, α‐2‐macroglobulin, low‐density lipoprotein cholesterol, IgM). This results in the improvement of blood flow and microcirculation initiated by lowering blood and plasma viscosity, and erythrocyte aggregation. In this context, microcirculation stands not only for the patency of small blood vessels, but for the complete interactive network between plasma, blood cells, the vessel wall, and cellular and extracellular compartments of the surrounding tissue. Insufficient tissue oxygenation leads to tissue damage, e.g., a microcirculatory disorder develops, creating acute as well as chronic symptoms. Therefore, impaired microcirculation has a rheologic, functional, and structural dimension with respect to involved organs or tissues. Rheopheresis represents a specific therapeutic approach with an acute rheologic as well as chronic functional and structural effects, which was confirmed in pilot and controlled clinical studies for several organ systems. Data from 2 controlled clinical trials are available for the safe and effective treatment in patients with age‐related macular degeneration.Keywords
This publication has 23 references indexed in Scilit:
- Extracorporeal Rheopheresis in the Treatment of Acute Ischemic StrokeStroke, 1999
- Laminar Shear StressArteriosclerosis, Thrombosis, and Vascular Biology, 1998
- LDL Hemoperfusion‐A New Procedure for LDL Apheresis: First Clinical Application of an LDL Adsorber Compatible with Human Whole BloodArtificial Organs, 1997
- Shear Stress as an Inhibitor of Vascular Smooth Muscle Cell ProliferationArteriosclerosis, Thrombosis, and Vascular Biology, 1997
- Hypercholesterinämie und Hyperfibrinogenämie beim Hörsturz*Laryngo-Rhino-Otologie, 1997
- The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19 435 patients with acute ischaemic strokeThe Lancet, 1997
- Low Density Lipoprotein Apheresis Improves Regional Myocardial Perfusion in Patients With Hypercholesterolemia and Extensive Coronary Artery DiseaseJACC, 1996
- Plasma Viscosity Increase with Progression of Peripheral Arterial Atherosclerotic DiseaseAngiology, 1996
- Hyperfibrinogenemia: An important risk factor for vascular complications in diabetesDiabetes Care, 1992
- The possible role of hemorheology in atherothrombogenesisAtherosclerosis, 1992